Buy Rohypnol (Flunitrazepam) Online-Rohypnol (Flunitrazepam) 1mg
Rohypnol is an intermediate-acting benzodiazepine with general properties similar to those of Valium (diazepam). It is used in the short-term treatment of insomnia, as a pre-medication in surgical procedures and for inducing anaesthesia. Like other benzodiazepines (such as Valium, Librium and Xanax), Rohypnol’s effects include sedation, muscle relaxation, reduction in anxiety, and prevention of convulsions.
Flunitrazepam, also known as Rohypnol among other names, is a benzodiazepine used to treat severe insomnia and assist with anesthesia. As with other hypnotics, flunitrazepam has been advised to be prescribed only on a short-term basis or by those with chronic insomnia on an occasional basis.
It was patented in 1962 and came into medical use in 1974. Flunitrazepam has been referred to as a date rape drug, though the percentage of reported rape cases in which it is involved is small.
Flunitrazepam as with other benzodiazepines can lead to drug dependence. Discontinuation may result in the appearance of withdrawal symptoms. Abrupt withdrawal may lead to a benzodiazepine withdrawal syndrome characterised by seizures, psychosis, insomnia, and anxiety. Rebound insomnia, worse than baseline insomnia, typically occurs after discontinuation of flunitrazepam even from short-term single nightly dose therapy.
Flunitrazepam impairs cognitive functions. This may appear as lack of concentration, confusion and anterograde amnesia. It can be described as a hangover-like effect which can persist to the next day. It also impairs psychomotor functions similar to other benzodiazepines and nonbenzodiazepine hypnotic drugs; falls and hip fractures were frequently reported. The combination with alcohol increases these impairments. Partial, but incomplete tolerance develops to these impairments.
Buy Rohypnol (Flunitrazepam) Online-Rohypnol (Flunitrazepam) 1mg Other adverse effects include:
- Slurred speech
- Gastrointestinal disturbances, lasting 12 or more hours
- Respiratory depression in higher doses